Affiliation:
1. Cardiovascular Department, Fuyang People’s Hospital Affiliated to Anhui Medical University, Fuyang, Anhui, China.
Abstract
Introduction:
The case report’s purpose is to remind doctors a rare complication named thrombocytopenia of antithrombotic drugs. As a result, severe bleeding or even life-threatening situations may be avoided.
Patient concerns:
A specific case of a patient with acute myocardial infarction, a significant decrease in platelet count was observed after percutaneous coronary intervention.
Diagnosis:
After ruling out other potential causes, the medical team considered tirofiban-induced thrombocytopenia as a possible explanation.
Interventions and outcomes:
Through careful monitoring and adjustment of medication, the patient’s platelet count eventually returned to normal.
Conclusion:
To ensure patient safety, it is advised to regularly monitor platelet counts at intervals of 2 to 6 hours before and after administering tirofiban.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tirofiban;Reactions Weekly;2024-01-06